Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,442 | -21,452 | -7,273 | -28,618 | -19,911 |
| Depreciation Amortization | 20 | 12 | 6 | 26 | 21 |
| Accounts payable and accrued liabilities | -1,301 | 118 | -1,662 | 1,663 | -285 |
| Other Working Capital | -4,595 | -380 | -2,419 | 452 | -1,208 |
| Other Operating Activity | 4,666 | 2,335 | 2,022 | -206 | 1,383 |
| Operating Cash Flow | $-34,652 | $-19,367 | $-9,326 | $-26,683 | $-20,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,030 | -14 | N/A | -17 | -12 |
| Investing Cash Flow | $-4,030 | $-14 | $N/A | $-17 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 78,644 | 58,575 | 24,155 | 5,939 | 5,005 |
| Other Financing Activity | 4,602 | 4,602 | 4,602 | 6,980 | 0 |
| Financing Cash Flow | $83,246 | $63,177 | $28,757 | $12,919 | $5,005 |
| Exchange Rate Effect | -16 | -23 | -15 | -4 | -3 |
| Beginning Cash Position | 11,349 | 11,349 | 11,349 | 25,134 | 25,134 |
| End Cash Position | 55,897 | 55,122 | 30,765 | 11,349 | 10,124 |
| Net Cash Flow | $44,548 | $43,773 | $19,416 | $-13,785 | $-15,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,652 | -19,367 | -9,326 | -26,683 | -20,000 |
| Capital Expenditure | -4,030 | -14 | N/A | -17 | -12 |
| Free Cash Flow | -38,682 | -19,381 | -9,326 | -26,700 | -20,012 |